Benjamin Gerald Tehan

This inventor holds 60 USPTO granted patents and 3 published patent applications, plus 9 CIPO patents and 19 EPO patents, primarily in Muscarinic Receptor Agonists (CPC class C07D). Top assignees: Heptares Therapeutics Limited, Nxera Pharma UK Limited, Allergan Pharmaceuticals International Limited. Active years: 2015-2025.

USPTO Granted Patents = 60 (Patent Applications = 3)

% Patents Active = 100.0

CIPO Patents = 9 (Patent Applications = 4)

EPO Patents = 19 (Patent Applications = 23)

Average Co-Inventor Count = 4.4

ph-index = 12

Forward Citations = 494(Granted Patents)

Forward Citations (Not Self Cited) = 79(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Hertfordshire, GB (2015 - 2016)
Welwyn Garden City, GB (2017 - 2019)
Welwyn Garden, GB (2017 - 2019)
Cambridge, GB (2019 - 2024)

Company Filing History:

53 out of 85

Heptares Therapeutics Limited

patents

6 out of 17

Nxera Pharma UK Limited

patents

1 out of 33

Allergan Pharmaceuticals International Limited

patents

4. 1 out of 834,307

Other

patents

where one patent can have more than one assignee

Years Active: 2015-2025

Loading Chart...

Areas of Expertise:

Muscarinic Agonists

Orexin Antagonists

mGlu5 Modulators

Pharmaceutical Compounds

Bicyclic Aza Compounds

Substituted Cyclohexanes

Inhibitors of Protease-Activated Receptor-2

Quinolinone Derivatives

60 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12415795 - 4-(3-cyanophenyl)-6-pyridinylpyrimidine mGlu5 modulators (2025-09-16),

2. 12331029 - Orexin 1 receptor antagonists (2025-06-17),

3. 12291512 - Oxime compounds as agonists of the muscarinic Mand/or Mreceptor (2025-05-06),

4. 12240825 - Oxexin 1 receptor antagonists (2025-03-04),

5. 12215099 - Quinolinone and benzoxazine derivatives as muscarinic Mand/or Mreceptor agonists (2025-02-04),

6. 12202843 - Muscarinic receptor agonists (2025-01-21),

7. 12024499 - Muscarinic agonists (2024-07-02),

8. 11945801 - Bicyclic aza compounds as muscarinic Mand/or Mreceptor agonists (2024-04-02),

9. 11834407 - Substituted cyclohexanes as muscarinic M1 receptor and/or M4 receptor agonists (2023-12-05),

10. 11793817 - Muscarinic M1 receptor agonists (2023-10-24),

11. 11773090 - Pharmaceutical compounds (2023-10-03),

12. 11680053 - Methods of treatment using 4-(3-cyanophenyl)-6-pyridinylpyrimidine mGlu5 modulators (2023-06-20),

13. 11584732 - Methods of treatment using 4-(3-cyanophenyl)-6-pyridinylpyrimidine mGlu5 modulators (2023-02-21),

14. 11352342 - Pharmaceutical compounds (2022-06-07),

15. 11324738 - Muscarinic agonists (2022-05-10),

Title: Inventor Benjamin Gerald Tehan

Introduction: Benjamin Gerald Tehan is a renowned inventor based in Cambridge, United Kingdom, known for his groundbreaking contributions to various technological fields.

Latest Patents: Benjamin Gerald Tehan holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing his diverse range of innovative ideas.

Career Highlights: With over two decades of experience in the innovation industry, Benjamin Gerald Tehan has successfully brought numerous inventions from concept to market, revolutionizing the way we interact with technology.

Collaborations: Throughout his career, Benjamin Gerald Tehan has collaborated with leading research institutions, universities, and tech companies to further develop his inventions and bring them to the global market.

Conclusion: Benjamin Gerald Tehan's passion for innovation and his relentless drive to push the boundaries of technology make him a true pioneer in the world of inventions.